High-dose monoclonal antibodies via the subcutaneous route: challenges and technical solutions, an industry perspective
- PMID: 22900469
- DOI: 10.4155/tde.12.68
High-dose monoclonal antibodies via the subcutaneous route: challenges and technical solutions, an industry perspective
Abstract
This review summarizes the various challenges in product development involved in subcutaneous administration of high-dose monoclonal antibodies and attempts to provide an industry perspective of some of the available technologies and potential avenues to overcome these challenges.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources